Ostarine (MK-2866 / enobosarm)

Ostarine is the most defensible SARM and still a hard thing to recommend, and both statements come from the same evidence. It has real, replicated human trials, and what those trials show is a modest effect the drug earns alongside a real liver signal, testosterone and HDL suppression, and a program that failed to win approval. The muscle effect of 1 to 1.5 kg of lean mass is real, the strength gains are documented, and the drug is reputedly the mildest in its class. None of that survives the practical picture. The liver-injury pattern is intrinsic and worsens at the doses people take, the compound is banned by WADA at all times (USADA 2024), and only about half of gray-market products contain what the label claims. Treat it as the SARM to understand, not the one to source and dose by forum protocol.

✅ Best for: Researchers, clinicians and analysts who need a reference point for where SARMs sit as a muscle-wasting therapy, since ostarine is the class's best-documented example. People comparing SARMs who want the honest state of the evidence rather than the vendor version, including how modest the real effect is. Writers covering the obesity and cancer-cachexia pipelines who want to track Veru's enobosarm program. Anyone weighing a SARM against a supervised option who wants the risks named plainly first.

❌ Avoid if: You want a muscle compound to take today, since ostarine is unapproved, carries an intrinsic cholestatic liver risk, and is sold only through channels with no purity guarantee. You are a tested athlete, because it is banned at all times and is the most-detected anabolic agent in doping cases. You have any liver condition or take other hepatically stressful drugs. You are unwilling to run regular bloodwork and manage hormonal suppression. You want the marketed non-suppressive profile, which the human data contradicts.